As we reach the middle of June, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and categories on BPIQ.com compared to XBI. We're currently running a 40% OFF ASCO sale, learn more here.
Table 1. BPIQ company weekly/monthly moves and YTD moves
Category | Weekly Move 6/13-6/17 | YTD Move |
|---|---|---|
All BPIQ Companies | -3.58% | -50.00% |
CAR-T Companies | -4.67% | -59.64% |
Gene Editing Companies | +1.25% | -57.48% |
XBI | +0.87% | -39.61% |
See the biggest moves from last week below:
Don't miss upcoming catalysts.. Get our weekly Catalyst Watchlist Free!
*We never send you spam - unsubscribe anytime
Highlights for the week
Biggest positive move
#DAWN +138.52% Day One Announces Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma.
Biggest negative move
#ADXN -57.51% Addex Terminates Dipraglurant Phase 2b/3 Study in Patients with Dyskinesia Associated with Parkinson’s Disease due to Slow Recruitment Rate.
Additional weekly big moves
#MREO +97.0% AstraZeneca plc (NASDAQ: AZN) is rumored to be eyeing take over of Mereo BioPharma Group plc (NASDAQ: MREO), according to a report in The Times.
#OPTN +84.9% Optinose Announces Positive Top-line Results of ReOpen2, its second Phase 3 Clinical Trial of XHANCE for Treatment of Chronic Sinusitis
#CLVS +78.8% Clovis Oncology Highlights Phase 1 Data from Ongoing Clinical Studies of Targeted Radiotherapy Candidate FAP-2286 at SNMMI Annual Meeting
#RIGL +64.2% The President of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), Raul Rodriguez, Just Bought 521% More Shares
#AKRO +42.4% Akero Therapeutics Announces Two Financing Transactions with Pfizer Inc. and Hercules Capital, Inc. Providing Access to Up To $125 Million
#RMTI +41.3%
#ACAD +14.2% Acadia gains 19% on FDA briefing docs on antipsychotic therapy
#AQST -17.4% Aquestive Therapeutics Reports Positive Initial Topline Data from Part 3 of EPIPHAST Trial Evaluating AQST-109 Epinephrine Oral Film
#CRBU -20.0% Caribou Biosciences Reports Positive Additional Data from CB-010 Allogeneic CAR-T Cell Therapy Phase 1 ANTLER Trial at the European Hematology Association (EHA) 2022 Hybrid Congress
#ACIU -25.5% AC Immune Provides Update On Alzheimer’s Prevention Initiative Study Evaluating Crenezumab In Autosomal Dominant Alzheimer’s Disease
#CFRX -29.4% Presentations at ASM Microbe Conference Demonstrate Potential of ContraFect’s Direct Lytic Agents (DLAs) to Address MRSA Infections
#RDHL -29.7% RedHill Biopharma to Host First Quarter 2022 Financial Results and Operational Highlights Webcast on June 23, 2022
#IPHA -30.3%
#VALN -31.5% Valneva Provides Update on European Inactivated, Whole-Virus COVID-19 Vaccine Program VLA2001
#IMV -34.9%
#CLNN -42.5%
#CALA -43.8% Calithera Biosciences Announces 1-for-20 reverse stock split
Highlights for next week
To see next week's Big Movers HERE, subscribe. Learn more here.
$SRRK Phase 3 update
$EWTX Phase 2 update
See our June PDUFA list for remaining target action date for the month
See our Big Movers post to learn about upcoming Movers throughout June and PDUFAs, after subscribing. Learn more here.
Comments